Evidence map›Paper›PMID 39223327›Full record

ArticleCommunications biology2024

Enabling target-aware molecule generation to follow multi objectives with Pareto MCTS.

Yaodong Yang, Guangyong Chen, Jinpeng Li, Junyou Li, Odin Zhang, Xujun Zhang, Lanqing Li, Jianye Hao, Ercheng Wang, Pheng-Ann Heng

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Applying Deep-Learning-DrivenJournal of medicinal chemistry · 2026
    Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yaodong YangDepartment of Computer Science and Engineering, The Chinese University of Hong Kong, Hong Kong, China.ORCID 0000-0001-8660-2376
Guangyong ChenZhejiang Lab, Hangzhou, China. gychen@zhejianglab.com.ORCID 0000-0002-5892-8608
Jinpeng LiDepartment of Computer Science and Engineering, The Chinese University of Hong Kong, Hong Kong, China.
Junyou LiZhejiang Lab, Hangzhou, China.
Odin ZhangZhejiang University, Hangzhou, China.
Xujun ZhangZhejiang University, Hangzhou, China.
Lanqing LiZhejiang Lab, Hangzhou, China.ORCID 0000-0003-1998-4022
Jianye HaoNoah's Ark Lab, Huawei, Shenzhen, China. jianye.hao@tju.edu.cn.ORCID 0000-0002-0422-8235
Ercheng WangZhejiang Lab, Hangzhou, China. wangec@zju.edu.cn.ORCID 0000-0003-2074-4077
Pheng-Ann HengDepartment of Computer Science and Engineering, The Chinese University of Hong Kong, Hong Kong, China.

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22377111
6 · The paper itself

Abstract

Target-aware drug discovery has greatly accelerated the drug discovery process to design small-molecule ligands with high binding affinity to disease-related protein targets. Conditioned on targeted proteins, previous works utilize various kinds of deep generative models and have shown great potential in generating molecules with strong protein-ligand binding interactions. However, beyond binding affinity, effective drug molecules must manifest other essential properties such as high drug-likeness, which are not explicitly addressed by current target-aware generative methods. In this article, aiming to bridge the gap of multi-objective target-aware molecule generation in the field of deep learning-based drug discovery, we propose ParetoDrug, a Pareto Monte Carlo Tree Search (MCTS) generation algorithm. ParetoDrug searches molecules on the Pareto Front in chemical space using MCTS to enable synchronous optimization of multiple properties. Specifically, ParetoDrug utilizes pretrained atom-by-atom autoregressive generative models for the exploration guidance to desired molecules during MCTS searching. Besides, when selecting the next atom symbol, a scheme named ParetoPUCT is proposed to balance exploration and exploitation. Benchmark experiments and case studies demonstrate that ParetoDrug is highly effective in traversing the large and complex chemical space to discover novel compounds with satisfactory binding affinities and drug-like properties for various multi-objective target-aware drug discovery tasks.

Indexed as

Drug DiscoveryMonte Carlo MethodAwarenessHumansMachine Learning

Identifiers

PMID39223327
PMCPMC11368924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.